Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
Bullous pemphigoid (BP) is a cutaneous disease triggered by numerous stimuli, where genetic milieu-influenced autoimmunity to hemidesmosomal proteins, namely, BP180 and/or BP230 initiate an inflammation leading to dermal-epidermal junction (DEJ) enzymatic pathological remodelling. Here, to the best...
Guardado en:
Autores principales: | Anna Rosińska-Więckowicz, Magdalena Jałowska, Monika Bowszyc-Dmochowska, Marian Dmochowski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/550b6587ad1743099d3911f716ddc3a7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
por: Maryam Aghighi, et al.
Publicado: (2020) -
Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
por: Vito Di Lernia, et al.
Publicado: (2020) -
Mucous Membrane Pemphigoid-Associated Malignancies. Case Series and a Brief Overview of the Literature
por: Michelangelo La Placa, et al.
Publicado: (2019) -
Bullous pemphigoid induced by Hijama therapy (cupping)
por: Arghavan Azizpour, et al.
Publicado: (2018) -
Successful induction treatment of bullous pemphigoid using reslizumab: a case report
por: Hyo-In Rhyou, et al.
Publicado: (2021)